EDIT
Price
$3.48
Change
-$0.19 (-5.18%)
Updated
Jul 9, 12:12 PM (EDT)
Capitalization
575.48M
27 days until earnings call
Intraday BUY SELL Signals
LYEL
Price
$15.17
Change
-$0.23 (-1.49%)
Updated
Jul 9, 11:47 AM (EDT)
Capitalization
371.25M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDIT vs LYEL

EDIT vs LYEL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EDIT vs. LYEL commentary
Jul 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and LYEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2026
Stock price -- (EDIT: $3.75 vs. LYEL: $15.91)
Brand notoriety: EDIT and LYEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 61% vs. LYEL: 90%
Market capitalization -- EDIT: $575.48M vs. LYEL: $371.25M
EDIT [@Biotechnology] is valued at $575.48M. LYEL’s [@Biotechnology] market capitalization is $371.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $126.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileLYEL’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • LYEL’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 5 TA indicator(s) are bullish while LYEL’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 5 bullish, 5 bearish.
  • LYEL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both EDIT and LYEL are a good buy in the short-term.

Price Growth

EDIT (@Biotechnology) experienced а +14.33% price change this week, while LYEL (@Biotechnology) price change was +22.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.30%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +2081.61%.

Reported Earning Dates

EDIT is expected to report earnings on Aug 05, 2026.

LYEL is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+3.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($575M) has a higher market cap than LYEL($371M). EDIT YTD gains are higher at: 82.927 vs. LYEL (-48.311). EDIT has higher annual earnings (EBITDA): -100.08M vs. LYEL (-178.09M). LYEL has more cash in the bank: 254M vs. EDIT (124M). EDIT has less debt than LYEL: EDIT (17.3M) vs LYEL (39.5M). EDIT has higher revenues than LYEL: EDIT (38.7M) vs LYEL (31K).
EDITLYELEDIT / LYEL
Capitalization575M371M155%
EBITDA-100.08M-178.09M56%
Gain YTD82.927-48.311-172%
P/E RatioN/AN/A-
Revenue38.7M31K124,839%
Total Cash124M254M49%
Total Debt17.3M39.5M44%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITLYEL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signal:
Gain/Loss:
LYEL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JUEZX27.47N/A
N/A
JPMorgan US Equity R2
NSDVX25.52N/A
N/A
North Star Dividend I
GCMUX40.54N/A
N/A
Goldman Sachs Mid Cap Value R6
OWACX27.88N/A
N/A
Old Westbury All Cap Core
AMFEX21.24N/A
N/A
AAMA Equity

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
N/A
VCYT - LYEL
46%
Loosely correlated
N/A
RKTO - LYEL
40%
Loosely correlated
N/A
BEAM - LYEL
39%
Loosely correlated
N/A
IMTX - LYEL
38%
Loosely correlated
N/A
EDIT - LYEL
38%
Loosely correlated
N/A
More